In a recent interview with Urology Times, fellow Joshua Heiman, M.D., discussed data from NIH-funded POuND OUT study. Data from an 18-month feasibility trial, which were presented at the 2025 American Urological Association Annual Meeting, show promising results for the treatment of uric acid nephrolithiasis with a combination of phentermine and topiramate.
